Rapid non-destructive volumetric tumor yield assessment in fresh lung core needle biopsies using polarization sensitive optical coherence tomography.


Journal

Biomedical optics express
ISSN: 2156-7085
Titre abrégé: Biomed Opt Express
Pays: United States
ID NLM: 101540630

Informations de publication

Date de publication:
01 Sep 2021
Historique:
received: 04 06 2021
revised: 30 07 2021
accepted: 01 08 2021
entrez: 25 10 2021
pubmed: 26 10 2021
medline: 26 10 2021
Statut: epublish

Résumé

Adequate tumor yield in core-needle biopsy (CNB) specimens is essential in lung cancer for accurate histological diagnosis, molecular testing for therapeutic decision-making, and tumor biobanking for research. Insufficient tumor sampling in CNB is common, primarily due to inadvertent sampling of tumor-associated fibrosis or atelectatic lung, leading to repeat procedures and delayed diagnosis. Currently, there is no method for rapid, non-destructive intraprocedural assessment of CNBs. Polarization-sensitive optical coherence tomography (PS-OCT) is a high-resolution, volumetric imaging technique that has the potential to meet this clinical need. PS-OCT detects endogenous tissue properties, including birefringence from collagen, and degree of polarization uniformity (DOPU) indicative of tissue depolarization. Here, PS-OCT birefringence and DOPU measurements were used to quantify the amount of tumor, fibrosis, and normal lung parenchyma in 42 fresh, intact lung CNB specimens. PS-OCT results were compared to and validated against matched histology in a blinded assessment. Linear regression analysis showed strong correlations between PS-OCT and matched histology for quantification of tumors, fibrosis, and normal lung parenchyma in CNBs. PS-OCT distinguished CNBs with low tumor content from those with higher tumor content with high sensitivity and specificity. This study demonstrates the potential of PS-OCT as a method for rapid, non-destructive, label-free intra-procedural tumor yield assessment.

Identifiants

pubmed: 34692203
doi: 10.1364/BOE.433346
pii: 433346
pmc: PMC8515979
doi:

Types de publication

Journal Article

Langues

eng

Pagination

5597-5613

Subventions

Organisme : NHLBI NIH HHS
ID : K23 HL132120
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL152075
Pays : United States

Informations de copyright

© 2021 Optical Society of America under the terms of the OSA Open Access Publishing Agreement.

Déclaration de conflit d'intérêts

LPH: Boehringer Ingelheim, Pliant Therapeutics, LX Medical, and Biogen Idec. MJS: NinePoint Medical, LX Medical.

Références

N Engl J Med. 2011 Aug 4;365(5):395-409
pubmed: 21714641
Gastrointest Endosc. 2008 Oct;68(4):745-53
pubmed: 18926183
Biomed Opt Express. 2017 Sep 26;8(10):4729-4741
pubmed: 29082098
J Vis Exp. 2013 Jan 22;(71):
pubmed: 23381470
J Oncol Pract. 2018 Oct 4;:JOP1800092
pubmed: 30285529
Chest. 2012 Aug;142(2):385-393
pubmed: 21980059
Biomed Opt Express. 2019 Jul 24;10(8):4190-4206
pubmed: 31453004
Science. 1991 Nov 22;254(5035):1178-81
pubmed: 1957169
Cancer Cytopathol. 2013 Jan;121(1):4-8
pubmed: 22760969
J Biomed Opt. 2002 Jul;7(3):359-71
pubmed: 12175285
Arch Ophthalmol. 1995 Mar;113(3):325-32
pubmed: 7887846
Ann Thorac Surg. 2007 Dec;84(6):1825-9
pubmed: 18036892
Eur Respir J. 2014 Oct;44(4):1011-22
pubmed: 25102961
Chest. 2007 Sep;132(3 Suppl):131S-148S
pubmed: 17873165
Opt Lett. 2014 Dec 15;39(24):6783-6
pubmed: 25502996
JAMA. 2012 Jun 13;307(22):2418-29
pubmed: 22610500
JACC Cardiovasc Imaging. 2008 Nov;1(6):752-61
pubmed: 19356512
Cancer Res. 2020 Apr 15;80(8):1773-1783
pubmed: 32295783
Clin Cancer Res. 2019 Sep 1;25(17):5242-5249
pubmed: 31175092
Am J Respir Crit Care Med. 2013 Jan 15;187(2):125-9
pubmed: 23322794
Biomed Opt Express. 2019 May 30;10(6):3070-3091
pubmed: 31259075
Opt Express. 2013 Jul 15;21(14):16353-69
pubmed: 23938487
Pathology. 2017 Oct;49(6):611-617
pubmed: 28811084
Sci Rep. 2016 Jul 01;6:28771
pubmed: 27364229
Sci Transl Med. 2016 Oct 5;8(359):359ra131
pubmed: 27708064
Nat Med. 2006 Dec;12(12):1429-33
pubmed: 17115049
Cancer Res. 2015 Oct 1;75(19):4032-41
pubmed: 26282168
Biomed Opt Express. 2018 Feb 09;9(3):1082-1096
pubmed: 29541505
Opt Lett. 2020 May 15;45(10):2748-2751
pubmed: 32412457
Histopathology. 2012 Mar;60(4):531-46
pubmed: 21916947
Oncologist. 2019 Dec;24(12):1570-1576
pubmed: 31152082
J Thorac Oncol. 2006 May;1(4):324-7
pubmed: 17409878
Biomed Opt Express. 2017 Feb 24;8(3):1838-1873
pubmed: 28663869
J Thorac Oncol. 2010 Apr;5(4):448-52
pubmed: 20125040
Biomed Opt Express. 2018 Nov 28;9(12):6519-6528
pubmed: 31065446
Nat Biomed Eng. 2017 Jul;1(7):
pubmed: 29750130
JCO Precis Oncol. 2018;2018:
pubmed: 30370396

Auteurs

Sreyankar Nandy (S)

Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA 02110, USA.
Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02110, USA.
Harvard Medical School, Boston, MA 02110, USA.

Timothy L Helland (TL)

Harvard Medical School, Boston, MA 02110, USA.
Department of Pathology, Massachusetts General Hospital, Boston, MA 02110, USA.

Benjamin W Roop (BW)

Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA 02110, USA.

Rebecca A Raphaely (RA)

Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA 02110, USA.
Harvard Medical School, Boston, MA 02110, USA.

Amy Ly (A)

Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02110, USA.
Harvard Medical School, Boston, MA 02110, USA.

Madelyn Lew (M)

Department of Pathology, University of Michigan, Ann Arbor, MI 48104, USA.

Sarita R Berigei (SR)

Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA 02110, USA.

Martin Villiger (M)

Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02110, USA.
Harvard Medical School, Boston, MA 02110, USA.

Anastasia Sorokina (A)

Department of Pathology, University of Illinois at Chicago, Chicago, IL 60131, USA.
Department of Pathology, Research Institute of Human Morphology, Moscow 103132, Russia.

Margit V Szabari (MV)

Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA 02110, USA.
Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02110, USA.
Harvard Medical School, Boston, MA 02110, USA.

Florian J Fintelmann (FJ)

Harvard Medical School, Boston, MA 02110, USA.
Department of Radiology, Massachusetts General Hospital, Boston, MA 02110, USA.

Melissa J Suter (MJ)

Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA 02110, USA.
Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02110, USA.
Harvard Medical School, Boston, MA 02110, USA.

Lida P Hariri (LP)

Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA 02110, USA.
Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02110, USA.
Harvard Medical School, Boston, MA 02110, USA.
Department of Pathology, Massachusetts General Hospital, Boston, MA 02110, USA.

Classifications MeSH